{
    "2021-06-21": [
        [
            {
                "time": "",
                "original_text": "鹏扬元合量化股票一季报：股票仓位为89.18%，重仓新宙邦、康泰生物等",
                "features": {
                    "keywords": [
                        "鹏扬元合",
                        "量化",
                        "股票",
                        "一季报",
                        "股票仓位",
                        "89.18%",
                        "新宙邦",
                        "康泰生物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：医疗服务会是下半年医药最强音么？强调重视康复医疗赛道",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业周报",
                        "医疗服务",
                        "下半年",
                        "康复医疗",
                        "康泰生物"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗服务",
                        "康复医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}